Pharmanutra S.p.A. (PHN.MI)

54.00

-0.30

(-0.55%)

At close: 5:35:15 PM GMT+2

Key Events

Advanced Chart

Loading Chart for PHN.MI

Previous Close 54.30
Open 54.30
Bid 56.30 x --
Ask 54.60 x --
Day's Range 53.60 - 55.10
52 Week Range 44.85 - 61.20
Volume 5,852
Avg. Volume 10,402
Market Cap (intraday) 518.575M
Beta (5Y Monthly) 0.30
PE Ratio (TTM) 31.21
EPS (TTM) 1.73
Earnings Date --
Forward Dividend & Yield 1.00 (1.84%)
Ex-Dividend Date May 5, 2025
1y Target Est 83.00

Pharmanutra S.p.A., a pharmaceutical and nutraceutical company, researches, designs, develops, and markets nutritional supplements and medical devices in Italy, Europe, the Middle East, South America, Far East, and internationally. The company produces and distributes raw materials and active ingredients for the food, pharmaceutical, and dietary supplement industries. It also offers iron deficiency, inflammation, mineral and vitamin, muscle and joint, sports nutrition, ophthalmic, and night rest products; and medical instrumentation and software for body bioimpedance analysis. The company sells its products through sales representatives, wholesalers, pharmacies, para-pharmacies, agents, distributors, online sales, local partners, and tenders. Pharmanutra S.p.A. was founded in 2003 and is based in Pisa, Italy.

www.pharmanutra.it

118

Full Time Employees

December 31

Fiscal Year Ends

Healthcare

Sector

Drug Manufacturers - Specialty & Generic

Industry

Trailing total returns as of 5/7/2025, which may include dividends or other distributions. Benchmark is FTSE MIB Index (FTSEMIB.MI) .

YTD Return

PHN.MI

1.11%

FTSE MIB Index (FTSEMIB.MI)

12.09%

1-Year Return

PHN.MI

8.28%

FTSE MIB Index (FTSEMIB.MI)

11.91%

3-Year Return

PHN.MI

3.07%

FTSE MIB Index (FTSEMIB.MI)

63.23%

5-Year Return

PHN.MI

145.24%

FTSE MIB Index (FTSEMIB.MI)

122.21%

Compare

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

PHN.MI

Pharmanutra S.p.A.

54.00

-0.55%

Mkt Cap EUR 518.575M